Last edition
News about
Azenta Life Sciences Expands Cap Carrier Range to Boost Lab Efficiency
Azenta Life Sciences has expanded its range of cap carriers with the introduction of new 24- and 48-format options, offering researchers greater flexibility and scalability to streamline sample tube processing workflows across diverse laboratory applications.
Sanofi India Names Deepak Arora as MD Starting October 27, 2025
Approved by Sanofi India’s Board, the appointment places Deepak Arora in charge of steering the company’s strategic priorities and operations in line with its global vision.
GSK Gains Exclusive Rights to Syndivia's Prostate Cancer ADC
GSK has obtained exclusive rights from Syndivia for a preclinical Antibody-Drug Conjugate (ADC) targeting metastatic Castration-Resistant Prostate Cancer (mCRPC), addressing an urgent need for novel therapies. The agreement expands GSK’s oncology pipeline with a potential best-in-class ADC designed to deliver enhanced anti-tumour activity.
Genenta Science and Anemocyte expand collaboration to advance off-the-shelf LVV Plasmid DNA platform
Genenta Science, a pioneer in immuno-oncology, and Anemocyte, a leading provider of advanced therapy and nucleic acid solutions, have announced an expanded strategic collaboration focused on developing an off-the-shelf lentiviral vector (LVV) Plasmid DNA technology platform.
Merck KGaA Reports Sustained Efficacy and Safety of OGSIVEO in Phase-III Desmoid Tumour Study
Merck KGaA has released long-term phase-III data showing that OGSIVEO treatment for up to four years continues to deliver durable tumour reductions, improved response rates, sustained symptom relief, and a consistent safety profile in patients with desmoid tumours.
Sanofi's Efdoralprin Alfa Meets Key Goals in Phase-II AATD Emphysema Study
Efdoralprin Alfa was previously granted fast track and Orphan Drug Designation (ODD) by the US Food and Drug Administration (FDA) for the treatment of AATD Emphysema. It is currently under clinical investigation, and its safety and efficacy have not been evaluated by any regulatory authority.
Tive Report Warns of Widening Gap Between Pharma Industry Growth and Supply-Chain Readiness
Future of pharma supply chains: A new report by Tive has highlighted a widening gap between the pharmaceutical industry’s rapid growth and the readiness of its supply chains, a shortfall that could result in higher rates of product spoilage, regulatory penalties, and costly disruptions if left unresolved.
Fujitsu, Logistics Knight Japan (LKJ) and Isuzu Motors have announced a joint pilot project to build a platform for integrated management of pharmaceuticals across the entire logistics network – from manufacturing sites to final delivery destinations such as pharmacies and hospitals.
Eli Lilly Acquires Adverum to Embolden Gene-Therapy Eye-Care Ambitions
Eli Lilly has announced that it will acquire gene therapy developer Adverum Biotechnologies in a deal valued at up to USD 261.7 million, signalling a push into the ophthalmology space.
Biogen licences Vanqua Bio's immune-disorder drug in deal worth up to USD 1.06 billion
Biogen has entered into an agreement with Vanqua Bio to acquire global rights to an experimental oral therapy for immune-related disorders, in a deal valued at up to USD 1.06 billion.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy